Literature DB >> 31840201

Efficacy of folic acid as an adjunct to lithium therapy on manic-like behaviors, oxidative stress and inflammatory parameters in an animal model of mania.

Samira Menegas1, Gustavo C Dal-Pont1, José H Cararo1, Roger B Varela2, Jorge M Aguiar-Geraldo1, Taise Possamai-Della1, Monica L Andersen3, João Quevedo1,4,5,6, Samira S Valvassori7.   

Abstract

Evaluate the efficacy of folic acid (FA) as a therapeutic adjunct to lithium (Li) on the manic-like behaviors as well as parameters of oxidative stress and inflammation in an animal model of mania induced by m-amphetamine (m-AMPH). Wistar rats first received m-AMPH or saline (NaCl 0.9%, Sal) for 14 days. Between the 8th and 14th day, rats were treated with water, Li, FA or a combination of thereof drugs (Li + FA). Manic-like behaviors were assessed in the open-field test. Oxidative stress and inflammation parameters were assessed in the frontal cortex, striatum, and hippocampus. Administration of m-AMPH in rats significantly enhanced the exploratory and locomotor behaviors, as well as the risk-taking and stereotypic behaviors. Li + FA reversed these behavioral alterations elicited by m-AMPH. Administration of this psychostimulant also increased oxidative damage to lipids and proteins, whereas Li + FA reversed these oxidative damages. m-AMPH also induced an increase in the glutathione peroxidase (GPx) activity and a decrease in the glutathione reductase (GR) activity. Li + FA reversed the alteration in GR activity, but not in GPx activity. In addition, m-AMPH increased the IL-1β and TNF-α levels in the rat brain; Li + FA combined therapy reversed the alterations on these inflammatory parameters. FA administration per se reduced the increased TNF-α content induced by m-AMPH. Present study provides evidence that FA is effective as an adjunct to Li standard therapy on manic-like behaviors, oxidative stress and inflammatory parameters in a model of mania induced by m-AMPH.

Entities:  

Keywords:  Animal model of mania; Bipolar disorder; Folic acid; M-amphetamine

Mesh:

Substances:

Year:  2019        PMID: 31840201     DOI: 10.1007/s11011-019-00503-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  58 in total

1.  The efficacy of low-dose lithium: clinical, psychological and biological correlates.

Authors:  M T Abou-Saleh; A Coppen
Journal:  J Psychiatr Res       Date:  1989       Impact factor: 4.791

Review 2.  Review of nutritional supplements for the treatment of bipolar depression.

Authors:  Jeffrey J Rakofsky; Boadie W Dunlop
Journal:  Depress Anxiety       Date:  2013-12-18       Impact factor: 6.505

Review 3.  Nutritional psychiatry: the present state of the evidence.

Authors:  Wolfgang Marx; Genevieve Moseley; Michael Berk; Felice Jacka
Journal:  Proc Nutr Soc       Date:  2017-09-25       Impact factor: 6.297

4.  Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study.

Authors:  Rodrigo Machado-Vieira; Marcus V Zanetti; Maria C Otaduy; Rafael T De Sousa; Marcio G Soeiro-de-Souza; Alana C Costa; Andre F Carvalho; Claudia C Leite; Geraldo F Busatto; Carlos A Zarate; Wagner F Gattaz
Journal:  J Clin Psychopharmacol       Date:  2017-02       Impact factor: 3.153

Review 5.  Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.

Authors:  M Berk; F Kapczinski; A C Andreazza; O M Dean; F Giorlando; M Maes; M Yücel; C S Gama; S Dodd; B Dean; P V S Magalhães; P Amminger; P McGorry; G S Malhi
Journal:  Neurosci Biobehav Rev       Date:  2010-10-08       Impact factor: 8.989

6.  A pilot study of rapid lithium administration in the treatment of acute mania.

Authors:  P E Keck; S M Strakowski; J M Hawkins; E Dunayevich; K C Tugrul; J A Bennett; S L McElroy
Journal:  Bipolar Disord       Date:  2001-04       Impact factor: 6.744

7.  Folic acid enhances lithium prophylaxis.

Authors:  A Coppen; S Chaudhry; C Swade
Journal:  J Affect Disord       Date:  1986 Jan-Feb       Impact factor: 4.839

Review 8.  Mitochondrial Agents for Bipolar Disorder.

Authors:  Círia Pereira; Victor Chavarria; João Vian; Melanie Maree Ashton; Michael Berk; Wolfgang Marx; Olivia May Dean
Journal:  Int J Neuropsychopharmacol       Date:  2018-06-01       Impact factor: 5.176

9.  Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model.

Authors:  Shafique Ahmad; Bibhu Prasad Panda; Kanchan Kohli; Mohammad Fahim; Kiran Dubey
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

10.  Folate Augmentation of Treatment--Evaluation for Depression (FolATED): randomised trial and economic evaluation.

Authors:  Emma Bedson; Diana Bell; Daniel Carr; Ben Carter; Dyfrig Hughes; Andrea Jorgensen; Helen Lewis; Keith Lloyd; Andrew McCaddon; Stuart Moat; Joshua Pink; Munir Pirmohamed; Seren Roberts; Ian Russell; Yvonne Sylvestre; Richard Tranter; Rhiannon Whitaker; Clare Wilkinson; Nefyn Williams
Journal:  Health Technol Assess       Date:  2014-07       Impact factor: 4.014

View more
  6 in total

1.  Açaí (Euterpe oleracea Mart.) as a Potential Anti-neuroinflammatory Agent: NLRP3 Priming and Activating Signal Pathway Modulation.

Authors:  Francine Carla Cadoná; Diulie Valente de Souza; Tuyla Fontana; David Frederick Bodenstein; Andiara Prates Ramos; Michele Rorato Sagrillo; Mirian Salvador; Kennya Mota; Carolina Bordin Davidson; Euler Esteves Ribeiro; Ana Cristina Andreazza; Alencar Kolinski Machado
Journal:  Mol Neurobiol       Date:  2021-05-22       Impact factor: 5.590

2.  Effect of blueberry extract on energetic metabolism, levels of brain-derived neurotrophic factor, and Ca2+-ATPase activity in the hippocampus and cerebral cortex of rats submitted to ketamine-induced mania-like behavior.

Authors:  Luiza Spohr; Mayara Sandrielly Pereira Soares; Natália Pontes Bona; Nathalia Stark Pedra; Alethéa Gatto Barschak; Rafaela Martins Alvariz; Marcia Vizzotto; Claiton Leoneti Lencina; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Metab Brain Dis       Date:  2022-01-19       Impact factor: 3.584

3.  Transcriptome Changes in Three Brain Regions during Chronic Lithium Administration in the Rat Models of Mania and Depression.

Authors:  Dawid Szczepankiewicz; Piotr Celichowski; Paweł A Kołodziejski; Ewa Pruszyńska-Oszmałek; Maciej Sassek; Przemysław Zakowicz; Ewa Banach; Wojciech Langwiński; Kosma Sakrajda; Joanna Nowakowska; Magdalena Socha; Ewelina Bukowska-Olech; Joanna Pawlak; Joanna Twarowska-Hauser; Leszek Nogowski; Janusz K Rybakowski; Aleksandra Szczepankiewicz
Journal:  Int J Mol Sci       Date:  2021-01-24       Impact factor: 5.923

Review 4.  Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium.

Authors:  Kosma Sakrajda; Aleksandra Szczepankiewicz
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 5.  The Way to a Human's Brain Goes Through Their Stomach: Dietary Factors in Major Depressive Disorder.

Authors:  Janine Aly; Olivia Engmann
Journal:  Front Neurosci       Date:  2020-12-07       Impact factor: 4.677

Review 6.  Enlightened: addressing circadian and seasonal changes in photoperiod in animal models of bipolar disorder.

Authors:  Richard McCarty; Travis Josephs; Oleg Kovtun; Sandra J Rosenthal
Journal:  Transl Psychiatry       Date:  2021-07-05       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.